Skip to main content
Clinical Trials/NL-OMON44245
NL-OMON44245
Completed
Not Applicable

Influence of exogenous growth hormone administration on circulating levels of Klotho in paediatric patients with isolated growth hormone deficiency. - KLOGIC

Vrije Universiteit Medisch Centrum0 sites20 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Klotho levels in isolated growth hormone deficiency
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Subjects with newly diagnosed GHD according to the guideline \*Guideline for GH treatment in children\* with an indication for treatment with rhGH .
  • \- Boys \< 9 years old and girls \< 8 years old (pre\-pubertal).
  • \- No history of rhGH treatment in the last 6 months.
  • \- Providing informed consent by the parents.

Exclusion Criteria

  • \- Subjects with a combined pituitary hormone deficiency.
  • \- Patients taking medications or having concomitant illnesses likely to confound endpoint assessments (e.g.use of corticosteroids, androgens or anabole steroids, insulin).
  • \- Patients with hypothyroidism not adequately supplied with thyroid hormone.
  • \- Patients taking other experimental (i.e., non marketed) therapies.
  • \- Patients with any kind of kidney disease.
  • \- Patients with a single kidney.

Outcomes

Primary Outcomes

Not specified

Similar Trials